Project Name：Lacosamide 

Registration Classification：3.1

Formulations and specifications ：Tablets: 50,100,150,200 mg; Injection: 200mg: 20ml 

Indications：Used as an adjunct to medication combined with other drugs for the treatment of patients over 17 years of age with partial onset seizures .  Instead of oral formulations,injections are suitable for short-term ,but they should not be used in patients with oral administration .

Original Research Company：German company Schwarz BioSciences 

Progress ：Pharmaceutical Research in progress